6 May 2025 in EMERGENCY MEDICINE
Background. The main cardiovascular risk factors have been investigated over the past few decades. Key factors include dyslipidemia, high blood pressure, smoking, diabetes mellitus and obesity. According to research data, it is important to examine the significance of the homeostasis model of insulin resistance (HOMA-IR) in the Ukrainian population, particularly among individuals with cardio-metabolic risk factors that lead to the development of atherosclerotic, non-atherosclerotic cardiovascular diseases and metabolic complications. Materials and methods. One hundred and ninety-nine individuals were examined: 152 patients with stage I–II arterial hypertension (AH) and 47 individuals without any previously diagnosed diseases. All patients were stratified into six groups according to the number of components of metabolic syndrome (MetS): group 0 — no components of MetS (12 practically healthy individuals); group 1 — the presence of 1 component of MetS; group 2 — the presence of 2 components of MetS; group 3 — three-component MetS; group 4 — four-component MetS; group 5 — five-component MetS. Results. The involvement of a higher number of MetS components was associated with an increase in the IR marker — HOMA-IR. With an increase in the number of MetS components, the body mass index, waist circumference (WC), uric acid and glycemia indicators increased linearly. The incidence of prediabetes, hyperuricemia and AH increased linearly with an increase in the components of MetS. AH and abdominal obesity were early manifestations of metabolic changes. The statistical differences in cardiometabolic risk are more significant when the HOMA-IR exceeded 1.78. When the threshold was exceeded, a significant increase in WC, ttriglycerides, uric acid and C-reactive protein was found in the observed patient groups, and with HOMA-IR values > 3.89, the probability of detecting MetS signs significantly increases. Conclusions. With an increase in the components of MetS, even at the stage of its formation, an increase in the insulin resistance index — HOMA-IR was observed. Abdominal obesity and AH are the most common manifestations at the stage of MetS formation. The average HOMA-IR value of 3.89 aligns with the criteria of MetS, while HOMA-IR above 1.78 is associated with a significance of cardio-metabolic risk factors such as WC, triglycerides, uric acid and C-reactive protein.
2 January 2023 in Lviv clinical bulletin
DUDanylo Halytsky Lviv National Medical University
Danylo Halytsky Lviv National Medical University
RSRépublique Tunisienne Ministère de la Santé
République Tunisienne Ministère de la Santé
Introduction. The combination of erosive-ulcerative lesions (EUI) of the gastroduodenal zone with hypertension (HT) is a common phenomenon and is a modern medicine’s pressing issue. Taking nonsteroidal anti-inflammatory drugs (NSAIDs), including by patients with HT, is accompanied by prostaglandin synthesis suppression due to cyclooxygenase inhibition and results in an arterial pressure increase. Moreover, it should be mentioned that patients with HT have a higher risk of gastroduodenal lesions. The aim of the study. To explore the prostaglandin E2 content in the blood serum of patients with gastroduodenal erosive-ulcerative lesions without and with comorbid hypertension. Materials and methods. The research involved 20 patients with gastroduodenal EUI without comorbid HT and 30 patients with gastroduodenal EUI suffering comorbid HT. All patients went through general clinical examinations, esophagogastroduodenofibroscopy (EGDFS), and stool tests to verify H.pylori infection, with prostaglandin E2 (PGE2) content in blood serum being determined. Results. EGDFS showed that among patients with gastroduodenal EUI without comorbid HT, 25.00 % were diagnosed with gastric EUI; half of the cases (50.00 %) revealed duodenum lesions, and another 25.00 % – combined stomach and duodenum lesions. At the same time, patients with EUI combined with comorbid HT manifested more frequent (p-value less than 0.05) gastric localization of mucosal EUI (50.00 %); 16.67 % of patients had the duodenum lesions, while combined stomach and duodenum defects were observed in 33.33 %. H. pylori infection was confirmed in 13 patients (65.00 %) with EUI without comorbid HT and in 22 examined individuals (73.33 %) with the gastroduodenal zone EUI and comorbid HT. The endogenous PGE2 was significantly higher in patients who had only gastric mucosa and duodenum EUI without comorbid HT and amounted to 2135.79 ± 80.94 pg/ml (p-value less than 0.05), while patients with EUI and comorbid HT were tested a significantly lower PGE2 level in blood serum – 1513.55 ± 92.48 pg/ml. At the same time, the significantly lower PGE2 level in patients with EUI and comorbid HT compared to the similar indicator in patients without it explains the differences in the EUI distribution in both groups of patients revealed during endoscopic examination. Since a significantly weakened PGE2 synthesis leads to lower bicarbonate and mucus secretion and more intensive acid production, the balance between the aggression and protection factors is upset, which contributes to the EUI emergence mainly in the stomach’s antral part. The research has exposed no significant difference in PGE2 content in patients with duodenum mucosa EUI and those with a combination of gastric and duodenum mucosa lesions (p-value more than 0.05). Besides, the PGE2 content was tested significantly lower in patients with EUI gastric localization, than in those with combined ulcers (p-value less than 0.05). The presence or absence of H. pylori infection also did not affect the endogenous PGE2 level (p-value more than 0.05). Conclusions. The prostaglandin E2 content in the blood serum of patients with gastroduodenal erosive-ulcerative lesions with comorbid hypertension was notably lower than in patients with erosive-ulcerative lesions of the gastroduodenal zone without comorbid hypertension. Moreover, a significant prostaglandin E2 decrease in the blood serum of patients with gastroduodenal erosive-ulcerative lesions with comorbid hypertension upsets the balance between aggression and protection factors, which contributes to the emergence of erosive-ulcerative defects, mostly in the stomach.
5 June 2026 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
The aim: To investigate biomarkers of cardiac dysfunction (soluble ST2, interleukin-33, and NT-proBNP) in combatants after blast injury and compare them with patients diagnosed with chronic heart failure (HF) with preserved and mid-range left ventricular ejection fraction. Methods: A study involved 68 combatants who had sustained blast injuries, aged over 18. The comparison group consisted of patients with chronic HF with preserved and mid-range left ventricular ejection fraction in a compensated state; the control group included 26 apparently healthy individuals. All patients underwent a comprehensive echocardiographic examination. The levels of sST2, interleukin-33, and NT-proBNP were determined by enzyme-linked immunosorbent assay (ELISA, Abcam, Cambridge, UK). Results: Combatants showed a statistically significant increase in soluble sST2 compared to the control group (p=0.0062), which was comparable to the elevation observed in patients with HF (p=0.0930). In contrast to sST2, interleukin-33 levels were significantly lower, with the most substantial decrease observed in the combatant group. This may indicate a degree of depletion or trapping by sST2 decoy receptors in this patient cohort. A separate echocardiographic analysis was conducted. The results demonstrated that dysregulation of the ST2 pathway and reduced interleukin-33 levels were associated with increased left ventricular myocardial hypertrophy compared to the apparently healthy individuals. Discussion of results: Stress can induce systemic inflammation and activate the sympathoadrenal system, potentially impacting the IL-33/sST2 axis and promoting remodeling. It can be hypothesized that the reduced IL-33 levels in military personnel post-injury fail to provide a sufficient cardioprotective effect against pro-hypertrophic changes. IL-33 possesses cardioprotective properties, and sST2 acts as its decoy receptor; therefore, an increase in sST2 and/or a decrease in IL-33 creates an imbalance that may contribute to fibrosis and hypertrophy. This may explain why our study did not find a statistically significant difference in echocardiographic parameters (such as the LVMI) between the combatants and patients with HF with preserved or mid-range LVEF. Conclusions: sST2 is a sensitive biomarker of systemic inflammation, cardiac stretch, and metabolic dysregulation. In the military population, it could serve as a valuable diagnostic and prognostic tool. Further research is needed to evaluate its inclusion in the screening protocols for combatants.